Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
The neutrophil antimicrobial peptide cathelicidin drives Th17 responses during infection
Gwyer Findlay, Emily
(Principal Investigator)
University of Edinburgh
Overview
Fingerprint
Research output
(1)
Project Details
Status
Finished
Effective start/end date
15/07/19
→
14/01/21
Funding
UK-based charities:
£14,803.00
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Polypeptide Antibiotic Agent
Medicine and Dentistry
100%
Neutrophil
Medicine and Dentistry
100%
Cathelicidin
Medicine and Dentistry
100%
Antimicrobial Peptides
Biochemistry, Genetics and Molecular Biology
100%
Programmed Cell Death
Medicine and Dentistry
14%
Steady State
Medicine and Dentistry
14%
Neutrophilia
Medicine and Dentistry
14%
Th1 Cell
Medicine and Dentistry
14%
Research output
Research output per year
2021
2021
2021
1
Article
Research output per year
Research output per year
The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation
Minns, D., Smith, K. J., Alessandrini, V.,
Hardisty, G.
, Melrose, L., Jackson-Jones, L., MacDonald, A. S.,
Davidson, D. J.
& Gwyer Findlay, E. L.,
24 Feb 2021
,
In:
Nature Communications.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Polypeptide Antibiotic Agent
100%
Neutrophil
100%
Cathelicidin
100%
Antimicrobial Peptides
100%
T Cell
14%